Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026)

Grown Rogue International's (GRUSF) quarterly Non Operating Income came in at -$1.8 million in Q1 2026, down 186.21% year-on-year from $2.1 million in Q1 2025, and up 100.0% quarter-over-quarter from -$7349.3 billion in Q4 2025.

Grown Rogue International (GRUSF) Non Operating Income (2011 - 2026) Analysis & Trends

Grown Rogue International's Non Operating Income history runs 5 years deep, the most recent figure standing at -$1.8 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 186.21% year-over-year to -$1.8 million in Q1 2026; TTM through Mar 2026 was -$4803.7 billion, a 140.47% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 144.57% from the prior year.
  • Non Operating Income rose to -$1.8 million in Q1 2026 per GRUSF's latest filing, from -$7349.3 billion in the prior quarter.
  • Across five years, Non Operating Income topped out at $13256.2 billion in Q4 2024 and bottomed at -$7349.3 billion in Q4 2025.
  • The 4-year median for Non Operating Income is -$194852.0 (2023), against an average of $642.5 billion.
  • Across the five-year window, Non Operating Income jumped 2104792095.96% in 2024 and tumbled 186.21% in 2026, its largest moves.
  • Year by year, Non Operating Income stood at $629812.0 in 2023, then soared by 2104792095.96% to $13256.2 billion in 2024, then slumped by 155.44% to -$7349.3 billion in 2025, then soared by 100.0% to -$1.8 million in 2026.
  • Per Business Quant, the three latest GRUSF Non Operating Income figures stand at -$1.8 million (Q1 2026), -$7349.3 billion (Q4 2025), and $2545.6 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -216.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 20.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -7.50 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 53.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Grown Rogue International 99.97 Mn 92.67 Mn 3.96 Mn -1.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.80 Mn
Dec 31, 2025 -7,349.32 Bn
Sep 30, 2025 2,545.62 Bn
Jun 30, 2025 2.54 Mn
Mar 31, 2025 2.08 Mn
Dec 31, 2024 13,256.23 Bn
Sep 30, 2024 -1,385.07 Bn
Jun 30, 2024 -7.15 Mn
Mar 31, 2024 -4.72 Mn
Dec 31, 2023 629,812.00
Apr 30, 2023 -194,852.00
Nov 30, 2011 246,214.36
Feb 28, 2011 -84,234.48